BioAlliance Pharma

BioAlliance Pharma, Topotarget to merge

Wednesday, April 16, 2014

BioAlliance Pharma, an innovative company specialized in developing drugs within orphan oncology diseases, and Topotarget, a Scandinavian-based biopharmaceutical company, intend to merge to create an orphan oncology company with highly complementary pipelines of late-stage products addressing significant unmet medical needs.

[Read More]